First Majestic Silver stock jumps as silver hits a fresh record; CPI is next test for the rally
12 January 2026
1 min read

First Majestic Silver stock jumps as silver hits a fresh record; CPI is next test for the rally

New York, January 12, 2026, 12:08 EST — Regular session

  • Shares of First Majestic Silver jumped roughly 8% after silver reached a fresh all-time peak
  • Precious metals surged anew following the Justice Department’s action against Fed Chair Powell, which weighed on the dollar
  • Traders are now eyeing Tuesday’s U.S. CPI report as the next potential market mover

First Majestic Silver Corp. shares jumped roughly 8% to $20.42 by midday, following a strong surge in silver prices. The stock climbed as high as $20.60 during the session, with trading volume exceeding 16 million shares.

Silver’s surge grabbed attention as it hit a fresh record, with the market turning sharply toward macro themes again. Investors are leaning on bullion as a shield against policy shifts and geopolitical risks. Spot silver climbed to $85.75 an ounce, finishing up about 6.9%, while spot gold surged past $4,600. “Elevated uncertainty plays directly into the gold market,” said Michael Haigh, global head of commodities research at Societe Generale. 1

That uncertainty traces back to Washington. The dollar fell following Federal Reserve Chair Jerome Powell’s revelation that the Justice Department subpoenaed the central bank, raising fresh worries over political interference in U.S. monetary policy. “This just ended the dollar’s New Year bounce,” noted Marc Chandler, chief market strategist at Bannockburn Global Forex. 2

Other silver-linked miners followed suit. Hecla Mining jumped roughly 9%, Coeur Mining added around 7%, and Pan American Silver inched up about 3% by midday.

First Majestic, a leading silver producer, runs mines mainly in Mexico but holds assets in the U.S. too. Investors see a straightforward play here: rising silver prices can quickly boost both revenue and margins, though the stock tends to amplify the metal’s volatility. 3

Rate expectations have shifted. J.P. Morgan now sees the Fed’s next rate hike coming in 2027, with several other banks pushing their projections for cuts further into 2026. Traders, for the most part, are bracing for a hold at the Fed’s late-January meeting. (A basis point equals one-hundredth of a percentage point.) 4

The calendar is packed. The Fed’s next policy meeting is set for Jan. 27–28, with currency and metal markets showing mixed positioning ahead of it. 5

The rally carries a sharp risk: hotter-than-expected inflation data could reverse rate-cut bets in a flash, sending the dollar higher and wiping out silver’s gains just as fast. On top of that, mining stocks face their own hurdles—rising costs, ore grades, and geopolitical risks all loom large.

Traders have their eyes on Tuesday’s December U.S. consumer price index, due out at 8:30 a.m. ET. This data could shift expectations for interest rates—and influence silver prices along with miners like First Majestic. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Western Digital stock climbs even as Wall Street wobbles — what to know now
Previous Story

Western Digital stock climbs even as Wall Street wobbles — what to know now

Coinbase stock rises as Senate crypto bill fight puts stablecoin rewards back in play
Next Story

Coinbase stock rises as Senate crypto bill fight puts stablecoin rewards back in play

Go toTop